NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agilysys, Inc. ("Agilysys, Inc.") (NASDAQ:AGYS) concerning possible violations of federal securities laws. On January 21, 2025, Agilysys issued a press release announcing third quarter revenue below expectations and the company's own guidance, resulting in a significant revision to Agilysys' FY25 revenue guidance.

image for news Lost Money on Agilysys, Inc.(AGYS)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Universal Display Corporation ("Universal Display Corporation") (NASDAQ:OLED) concerning possible violations of federal securities laws. On August 1, 2024, Universal reported solid 2Q 2024 results and raised the bottom-end of its full year revenue outlook.

image for news An Investigation Has Commenced on Behalf of Universal Display Corporation Shareholders. Contact Levi & Korsinsky to Discuss your OLED Losses

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex Pharmaceuticals Incorporated ("Vertex Pharmaceuticals") (NASDAQ:VRTX) concerning possible violations of federal securities laws. On December 19, 2024, the company reported disappointing results from its RewinD-LB Phase 2b clinical trial for the pain drug suzetrigine.

image for news Levi & Korsinsky Announces an Investigation on Behalf of Vertex Pharmaceuticals Incorporated (VRTX) Shareholders Who May Have Been Affected by Fraud

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pacira-biosciences-inc-lawsuit-submission-form?prid=129472&wire=1 or contact Joseph E. Levi, Esq.

image for news Pacira BioSciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your Rights - PCRX

180 Degree Capital Corp. Issues Q4 2024 Shareholder Letter — Neutral

TURN   GlobeNewsWire — February 14, 2025

Montclair, NJ, Feb. 14, 2025 (GLOBE NEWSWIRE) -- 180 Degree Capital Corp. (NASDAQ:TURN) today issued the following Q4 2024 Shareholder Letter:

image for news 180 Degree Capital Corp. Issues Q4 2024 Shareholder Letter

NORWOOD, Mass., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) (“Corbus” or the “Company”), announced that data from its US and UK conducted first-in-human dose escalation clinical study (“Western study”) of CRB-701 (SYS6002) is being presented today at the 2025 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU).

image for news CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Triumph Financial, Inc. ("Triumph Financial, Inc.") (NASDAQ:TFIN) concerning possible violations of federal securities laws. On January 22, 2025, after market close, Triumph published a quarterly earnings report stating that it had a profit of $0.13 per share, missing the Zacks Consensus Estimate of $0.26 per share by 50%.

image for news Investors who lost money on Triumph Financial, Inc. should contact Levi & Korsinsky about an ongoing investigation - TFIN

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MSCI Inc. ("MSCI Inc.") (NYSE:MSCI) concerning possible violations of federal securities laws. On January 29, 2025, MSCI reported a 24.3% fall in 4Q profit stemming from an increase in operating expenses, as well as spending on employee incentives and compensation.

image for news MSCI Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations - MSCI

NEW YORK and MELBOURNE, Australia, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing oral combination medicines, today reported fiscal second quarter financial results and provided business highlights for the quarter ended December 31, 2024.

image for news Incannex Healthcare Inc. Reports Fiscal Second Quarter 2025 Financial Results and Business Updates

GCL Announces First Half Fiscal Year 2025 Unaudited Financial Results — Neutral

GCL   GlobeNewsWire — February 14, 2025

SINGAPORE, Feb. 14, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (Nasdaq: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced its financial results for the six months ended September 30, 2024.

image for news GCL Announces First Half Fiscal Year 2025 Unaudited Financial Results

3 Reasons Arm Holdings Is a Must-Buy for Long-Term Investors — Positive

ARM   The Motley Fool — February 14, 2025

Arm Holdings (ARM 6.06%) has emerged as a top AI stock following its initial public offering in September 2023. The chip design company, which specializes in power-efficient CPU architecture, seemed to be initially misunderstood by investors, but the stock has since tripled from its IPO price.

image for news 3 Reasons Arm Holdings Is a Must-Buy for Long-Term Investors

Owens Corning to Sell Glass Reinforcements Business to Praana Group — Neutral

OC   Business Wire — February 14, 2025

TOLEDO, Ohio & MUMBAI, India--(BUSINESS WIRE)--Owens Corning (NYSE: OC), a residential and commercial building products leader, and Praana Group, an India-based holding group that operates a diverse portfolio of companies primarily serving the industrial sector, announced today that they have signed a definitive agreement for the sale of Owens Corning's glass reinforcements business to Praana Group (through its subsidiaries) at an enterprise value of $755,000,000. This sale is a part of Owens C.

image for news Owens Corning to Sell Glass Reinforcements Business to Praana Group

Gold (XAU) Price Forecast: Bullish Momentum Builds as Trade War Fears Intensify — Positive

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  UGL   FXEmpire — February 14, 2025

Gold price nears record highs with $3,000 in sight as trade war fears fuel safe-haven demand. Will inflation and Fed policy keep the rally going?

image for news Gold (XAU) Price Forecast: Bullish Momentum Builds as Trade War Fears Intensify

We asked DeepSeek AI what will be Nvidia stock price at end of 2025 — Positive

NVDA   Finbold — February 14, 2025

So far 2025 has been rather unfavorable for Nvidia (NASDAQ: NVDA). While it was one of the best-performing stocks in the S&P 500 index last year, Nvidia shares have struggled to meaningfully move to the upside since January.

image for news We asked DeepSeek AI what will be Nvidia stock price at end of 2025

Silicon Valley's Sleeping Giant? Intel's Comeback in Focus — Positive

INTC   MarketBeat — February 14, 2025

Intel Corporation's NASDAQ: INTC stock price has jumped in recent trading sessions, accompanied by an increase in trading volume. The stock, currently trading around $24.62, has climbed by almost 10% in a single day and an impressive 27% over the past week.

image for news Silicon Valley's Sleeping Giant? Intel's Comeback in Focus

Fortis Inc. Files 2024 Year-End Disclosure Documents — Neutral

FTS   GlobeNewsWire — February 14, 2025

This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024.

image for news Fortis Inc. Files 2024 Year-End Disclosure Documents

Extending expertise in ERP consulting•implementation•operations across the region Driving client business innovation by integrating AI and cloud advancements into SAP's latest Cloud ERP solutions Delivering differentiated client value through LG CNS solutions such as 'PerfecTwin ERP Edition' and 'SINGLEX' SEOUL, South Korea , Feb. 14, 2025 /PRNewswire/ -- LG CNS today announced that it has joined SAP® Regional Strategic Services Partner (RSSP) initiative, established by SAP Asia Pacific (APAC) to amplify the capabilities and reach of established partners in the APAC region that are on a rapid growth trajectory. Through the RSSP initiative, SAP will provide strategic support to eligible …

image for news LG CNS Joins SAP Regional Strategic Services Partner Initiative in Asia Pacific

SAN ANTONIO , Feb. 14, 2025 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc., (NYSE:CCO) announced today that Scott Wells, Chief Executive Officer of Clear Channel Outdoor Holdings, Inc. and Clear Channel Outdoor Americas, is scheduled to present at Morgan Stanley's Technology, Media & Telecom Conference on Tuesday, March 4, 2025, at 2:35 p.m., Pacific Time.

image for news Clear Channel Outdoor Holdings, Inc. to Participate in Morgan Stanley's Technology, Media & Telecom Conference

AMC Networks Inc. Reports Fourth Quarter and Full Year 2024 Results — Neutral

AMCX   GlobeNewsWire — February 14, 2025

NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- AMC Networks Inc. ("AMC Networks" or the "Company") (NASDAQ: AMCX) today reported financial results for the fourth quarter and full year ended December 31, 2024. AMC Networks Chief Executive Officer Kristin Dolan said: "We are pleased and encouraged by our results in the fourth quarter and across all of 2024.

image for news AMC Networks Inc. Reports Fourth Quarter and Full Year 2024 Results

SAN JOSE, Calif. , Feb. 14, 2025 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its Chairman and CEO, Dr. Amit Kumar, was featured in an interview with Alpha Wolf Trading.

image for news Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview